Back to Search Start Over

Two parallel pathways connect glutamine metabolism and mTORC1 activity to regulate glutamoptosis

Authors :
Agencia Estatal de Investigación (España)
Ministerio de Ciencia, Innovación y Universidades (España)
European Commission
Ministerio de Economía y Competitividad (España)
Consejo Superior de Investigaciones Científicas (España)
Fondation pour la Recherche Médicale
Fondation ARC pour la Recherche sur le Cancer
Université de Bordeaux
Conseil régional d'Aquitaine
Ministre de l'Enseignement Supérieur, de la Recherche et de l'Innovation (France)
Bodineau, Clément
Tomé, Mercedes
Courtois, Sarah
Costa, Ana S. H.
Sciacovelli, Marco
Rousseau, Benoit
Richard, Elodie
Vacher, Pierre
Parejo-Pérez, Carlos
Bessède, Emilie
Varon, Christine
Soubeyran, Pierre
Frezza, Christian
Murdoch, Piedad del S.
Villar, Victor H.
Durán, Raúl V.
Agencia Estatal de Investigación (España)
Ministerio de Ciencia, Innovación y Universidades (España)
European Commission
Ministerio de Economía y Competitividad (España)
Consejo Superior de Investigaciones Científicas (España)
Fondation pour la Recherche Médicale
Fondation ARC pour la Recherche sur le Cancer
Université de Bordeaux
Conseil régional d'Aquitaine
Ministre de l'Enseignement Supérieur, de la Recherche et de l'Innovation (France)
Bodineau, Clément
Tomé, Mercedes
Courtois, Sarah
Costa, Ana S. H.
Sciacovelli, Marco
Rousseau, Benoit
Richard, Elodie
Vacher, Pierre
Parejo-Pérez, Carlos
Bessède, Emilie
Varon, Christine
Soubeyran, Pierre
Frezza, Christian
Murdoch, Piedad del S.
Villar, Victor H.
Durán, Raúl V.
Publication Year :
2021

Abstract

Glutamoptosis is the induction of apoptotic cell death as a consequence of the aberrant activation of glutaminolysis and mTORC1 signaling during nutritional imbalance in proliferating cells. The role of the bioenergetic sensor AMPK during glutamoptosis is not defined yet. Here, we show that AMPK reactivation blocks both the glutamine-dependent activation of mTORC1 and glutamoptosis in vitro and in vivo. We also show that glutamine is used for asparagine synthesis and the GABA shunt to produce ATP and to inhibit AMPK, independently of glutaminolysis. Overall, our results indicate that glutamine metabolism is connected with mTORC1 activation through two parallel pathways: an acute alpha-ketoglutarate-dependent pathway; and a secondary ATP/AMPK-dependent pathway. This dual metabolic connection between glutamine and mTORC1 must be considered for the future design of therapeutic strategies to prevent cell growth in diseases such as cancer.

Details

Database :
OAIster
Publication Type :
Electronic Resource
Accession number :
edsoai.on1306016772
Document Type :
Electronic Resource